ARCADIS NV (ARCAD.AS) Fundamental Analysis & Valuation

AMS:ARCAD • NL0006237562

Current stock price

26.52 EUR
-0.5 (-1.85%)
Last:

This ARCAD.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ARCAD.AS Profitability Analysis

1.1 Basic Checks

  • In the past year ARCAD was profitable.
  • ARCAD had a positive operating cash flow in the past year.
  • ARCAD had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ARCAD had a positive operating cash flow.
ARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 5.73%, ARCAD is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
  • With a decent Return On Equity value of 20.08%, ARCAD is doing good in the industry, outperforming 70.97% of the companies in the same industry.
  • ARCAD's Return On Invested Capital of 11.47% is fine compared to the rest of the industry. ARCAD outperforms 74.19% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ARCAD is in line with the industry average of 10.85%.
  • The 3 year average ROIC (11.41%) for ARCAD is below the current ROIC(11.47%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.73%
ROE 20.08%
ROIC 11.47%
ROA(3y)5.4%
ROA(5y)5.15%
ROE(3y)18.28%
ROE(5y)16.89%
ROIC(3y)11.41%
ROIC(5y)10.54%
ARCAD.AS Yearly ROA, ROE, ROICARCAD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 5.53%, ARCAD is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
  • ARCAD's Profit Margin has improved in the last couple of years.
  • ARCAD has a Operating Margin of 8.43%. This is in the better half of the industry: ARCAD outperforms 70.97% of its industry peers.
  • In the last couple of years the Operating Margin of ARCAD has grown nicely.
Industry RankSector Rank
OM 8.43%
PM (TTM) 5.53%
GM N/A
OM growth 3Y3.65%
OM growth 5Y2.3%
PM growth 3Y8.28%
PM growth 5Y48.85%
GM growth 3YN/A
GM growth 5YN/A
ARCAD.AS Yearly Profit, Operating, Gross MarginsARCAD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 4 6 8 10

5

2. ARCAD.AS Health Analysis

2.1 Basic Checks

  • ARCAD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for ARCAD has been reduced compared to 1 year ago.
  • The number of shares outstanding for ARCAD has been reduced compared to 5 years ago.
  • The debt/assets ratio for ARCAD is higher compared to a year ago.
ARCAD.AS Yearly Shares OutstandingARCAD.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ARCAD.AS Yearly Total Debt VS Total AssetsARCAD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.26 indicates that ARCAD is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ARCAD has a Altman-Z score (2.26) which is comparable to the rest of the industry.
  • ARCAD has a debt to FCF ratio of 3.01. This is a good value and a sign of high solvency as ARCAD would need 3.01 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.01, ARCAD belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
  • ARCAD has a Debt/Equity ratio of 0.80. This is a neutral value indicating ARCAD is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ARCAD (0.80) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 3.01
Altman-Z 2.26
ROIC/WACC1.71
WACC6.7%
ARCAD.AS Yearly LT Debt VS Equity VS FCFARCAD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • ARCAD has a Current Ratio of 1.02. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
  • ARCAD's Current ratio of 1.02 is in line compared to the rest of the industry. ARCAD outperforms 48.39% of its industry peers.
  • ARCAD has a Quick Ratio of 1.02. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
  • ARCAD's Quick ratio of 1.02 is in line compared to the rest of the industry. ARCAD outperforms 51.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
ARCAD.AS Yearly Current Assets VS Current LiabilitesARCAD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1

3. ARCAD.AS Growth Analysis

3.1 Past

  • ARCAD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.53%.
  • Looking at the last year, ARCAD shows a decrease in Revenue. The Revenue has decreased by -3.09% in the last year.
EPS 1Y (TTM)-13.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.8%
Revenue 1Y (TTM)-3.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.09%

3.2 Future

  • The Earnings Per Share is expected to decrease by -5.28% on average over the next years.
  • Based on estimates for the next years, ARCAD will show a small growth in Revenue. The Revenue will grow by 4.52% on average per year.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

ARCAD.AS Yearly Revenue VS EstimatesARCAD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
ARCAD.AS Yearly EPS VS EstimatesARCAD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

5

4. ARCAD.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.22 indicates a rather expensive valuation of ARCAD.
  • 77.42% of the companies in the same industry are more expensive than ARCAD, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of ARCAD to the average of the S&P500 Index (25.73), we can say ARCAD is valued slightly cheaper.
  • A Price/Forward Earnings ratio of 15.43 indicates a correct valuation of ARCAD.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ARCAD is on the same level as its industry peers.
  • ARCAD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.72, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.22
Fwd PE 15.43
ARCAD.AS Price Earnings VS Forward Price EarningsARCAD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 77.42% of the companies in the same industry are more expensive than ARCAD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ARCAD is valued cheaper than 90.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.38
EV/EBITDA 7.15
ARCAD.AS Per share dataARCAD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The decent profitability rating of ARCAD may justify a higher PE ratio.
  • A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

6

5. ARCAD.AS Dividend Analysis

5.1 Amount

  • ARCAD has a Yearly Dividend Yield of 3.62%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of ARCAD has falen by -23.41%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • ARCAD's Dividend Yield is a higher than the industry average which is at 2.62.
  • ARCAD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
Industry RankSector Rank
Dividend Yield 3.62%

5.2 History

  • The dividend of ARCAD is nicely growing with an annual growth rate of 91.86%!
Dividend Growth(5Y)91.86%
Div Incr Years6
Div Non Decr Years6
ARCAD.AS Yearly Dividends per shareARCAD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • 42.79% of the earnings are spent on dividend by ARCAD. This is a bit on the high side, but may be sustainable.
DP42.79%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
ARCAD.AS Yearly Income VS Free CF VS DividendARCAD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M
ARCAD.AS Dividend Payout.ARCAD.AS Dividend Payout, showing the Payout Ratio.ARCAD.AS Dividend Payout.PayoutRetained Earnings

ARCAD.AS Fundamentals: All Metrics, Ratios and Statistics

ARCADIS NV

AMS:ARCAD (3/20/2026, 4:27:17 PM)

26.52

-0.5 (-1.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)02-19
Earnings (Next)04-30
Inst Owners65.86%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap2.40B
Revenue(TTM)3.76B
Net Income(TTM)208.00M
Analysts78.95
Price Target48.56 (83.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.62%
Yearly Dividend1.01
Dividend Growth(5Y)91.86%
DP42.79%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.16%
Min Revenue beat(2)-5.68%
Max Revenue beat(2)1.36%
Revenue beat(4)1
Avg Revenue beat(4)-16.47%
Min Revenue beat(4)-35.5%
Max Revenue beat(4)1.36%
Revenue beat(8)1
Avg Revenue beat(8)-13.89%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.97%
PT rev (3m)-18.96%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-6.06%
EPS NY rev (3m)-8.64%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-10.25%
Revenue NY rev (3m)-10.95%
Valuation
Industry RankSector Rank
PE 17.22
Fwd PE 15.43
P/S 0.64
P/FCF 6.38
P/OCF 5.98
P/B 2.32
P/tB N/A
EV/EBITDA 7.15
EPS(TTM)1.54
EY5.81%
EPS(NY)1.72
Fwd EY6.48%
FCF(TTM)4.16
FCFY15.68%
OCF(TTM)4.43
OCFY16.72%
SpS41.57
BVpS11.46
TBVpS-4.83
PEG (NY)1.77
PEG (5Y)N/A
Graham Number19.92
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 20.08%
ROCE 16%
ROIC 11.47%
ROICexc 13.52%
ROICexgc 98.98%
OM 8.43%
PM (TTM) 5.53%
GM N/A
FCFM 10%
ROA(3y)5.4%
ROA(5y)5.15%
ROE(3y)18.28%
ROE(5y)16.89%
ROIC(3y)11.41%
ROIC(5y)10.54%
ROICexc(3y)13.31%
ROICexc(5y)12.46%
ROICexgc(3y)69.58%
ROICexgc(5y)59.19%
ROCE(3y)15.79%
ROCE(5y)14.57%
ROICexgc growth 3Y38.51%
ROICexgc growth 5Y19.6%
ROICexc growth 3Y18.13%
ROICexc growth 5Y2.93%
OM growth 3Y3.65%
OM growth 5Y2.3%
PM growth 3Y8.28%
PM growth 5Y48.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.8
Debt/FCF 3.01
Debt/EBITDA 1.86
Cap/Depr 19.08%
Cap/Sales 0.66%
Interest Coverage 4.01
Cash Conversion 89.51%
Profit Quality 180.77%
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 2.26
F-Score6
WACC6.7%
ROIC/WACC1.71
Cap/Depr(3y)24.86%
Cap/Depr(5y)27.76%
Cap/Sales(3y)0.97%
Cap/Sales(5y)1.12%
Profit Quality(3y)157.97%
Profit Quality(5y)166.97%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-21.8%
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)-3.09%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%24.09%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y-18.51%
EBIT growth 3Y11.52%
EBIT growth 5Y11.06%
EBIT Next Year40.87%
EBIT Next 3Y15.76%
EBIT Next 5Y14.66%
FCF growth 1Y23.28%
FCF growth 3Y15.52%
FCF growth 5Y-1.42%
OCF growth 1Y14.57%
OCF growth 3Y12.18%
OCF growth 5Y-1.34%

ARCADIS NV / ARCAD.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARCADIS NV?

ChartMill assigns a fundamental rating of 5 / 10 to ARCAD.AS.


What is the valuation status for ARCAD stock?

ChartMill assigns a valuation rating of 5 / 10 to ARCADIS NV (ARCAD.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for ARCADIS NV?

ARCADIS NV (ARCAD.AS) has a profitability rating of 7 / 10.


What are the PE and PB ratios of ARCADIS NV (ARCAD.AS) stock?

The Price/Earnings (PE) ratio for ARCADIS NV (ARCAD.AS) is 17.22 and the Price/Book (PB) ratio is 2.32.


What is the financial health of ARCADIS NV (ARCAD.AS) stock?

The financial health rating of ARCADIS NV (ARCAD.AS) is 5 / 10.